XML 69 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies, Discontinued Operations (FY) (Details) - USD ($)
May 31, 2018
Apr. 30, 2018
Discontinued Operations [Abstract]    
Fair value of divested entities $ 1,495,000  
Gain (loss) on divestiture $ 0  
WMG Pharma GmbH    
Discontinued Operations [Abstract]    
Equity interest sold   100.00%
Consideration amount   $ 13,490